Literature DB >> 21675838

Examining the role of cyclin D1 in breast cancer.

Marco A Velasco-Velázquez1, Zhiping Li, Mathew Casimiro, Emanuele Loro, Nora Homsi, Richard G Pestell.   

Abstract

Cyclin D1 overexpression is found in more than 50% of human breast cancers and causes mammary cancer in transgenic mice. Dysregulation of cyclin D1 gene expression or function contributes to the loss of normal cell cycle control during tumorigenesis. Recent studies have demonstrated that cyclin D1 conducts additional specific functions to regulate gene expression in the context of local chromatin, promote cellular migration and inhibit mitochondrial metabolism. It is anticipated that these additional functions contribute to the pathology associated with dysregulated cyclin D1 abundance. This article discusses evidence that examines the significance of cyclin D1 in breast cancer with emphasis on its role in breast cancer stem cell expansion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21675838     DOI: 10.2217/fon.11.56

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  32 in total

1.  Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

Authors:  Adrian Britschgi; Anke Bill; Heike Brinkhaus; Christopher Rothwell; Ieuan Clay; Stephan Duss; Michael Rebhan; Pichai Raman; Chantale T Guy; Kristie Wetzel; Elizabeth George; M Oana Popa; Sarah Lilley; Hedaythul Choudhury; Martin Gosling; Louis Wang; Stephanie Fitzgerald; Jason Borawski; Jonathan Baffoe; Mark Labow; L Alex Gaither; Mohamed Bentires-Alj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 2.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

Review 3.  Breast cancer stem cells.

Authors:  Marco A Velasco-Velázquez; Nora Homsi; Marisol De La Fuente; Richard G Pestell
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

4.  New insights into tumor dormancy: Targeting DNA repair pathways.

Authors:  Elizabeth B Evans; Shiaw-Yih Lin
Journal:  World J Clin Oncol       Date:  2015-10-10

Review 5.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

6.  p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.

Authors:  Weibing Zhou; Xiaoyan Guan; Longyun Wang; Yuping Liao; Juan Huang
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-25       Impact factor: 4.553

7.  Cyclin D1 localizes in the cytoplasm of keratinocytes during skin differentiation and regulates cell-matrix adhesion.

Authors:  Rita Fernández-Hernández; Marta Rafel; Noel P Fusté; Rafael S Aguayo; Josep M Casanova; Joaquim Egea; Francisco Ferrezuelo; Eloi Garí
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

8.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.

Authors:  Radha Munagala; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

9.  Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.

Authors:  Elizabeth Tarasewicz; Lisbi Rivas; Randala Hamdan; Danijela Dokic; Vamsi Parimi; Beatriz Penalver Bernabe; Alexandra Thomas; Lonnie D Shea; Jacqueline S Jeruss
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.

Authors:  Abhik Saha; Erle S Robertson
Journal:  Future Microbiol       Date:  2013-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.